Future Research Directions in AOM Timing As newer anti-obesity medications enter clinical practice, understanding their potential in early intervention for GLP-1 non-responders becomes increasingly crucial
Oral semaglutide was approved in 2019 as an adjunct to diet and exercise to improve glycemic control in adults with T2D [24]
The Partnership for Safe Medicines (PSM) is pushing the Food and Drug Administration to call a timeout on the spot promoting its version of the weight-loss drug Ozempic
GlyNAC (glycine and N-acetylcysteine) supplementation in mice increases length of life by correcting glutathione deficiency, oxidative stress, mitochondrial dysfunction, abnormalities in mitophagy and nutrient sensing, and genomic damage
Annu Rev Biochem 52:711760 Mendoza-Czatl DG, Butko E, Springer F, Torpey JW, Komives EA, Kehr J, Schroeder JI (2008) Identification of high levels of phytochelatins, glutathione and cadmium in the phloem sap of Brassica napus